Effects of Voluntary and Forced Exercise on Anxiety-Related Behaviours and Motor Activity in Parkinson Mouse Model

Effects of Voluntary and Forced Exercise on Anxiety-Related Behaviours and Motor Activity in Parkinson Mouse Model

Objective: The aim of this study was to investigate the effect of two different types of exercise, voluntary and forced, on motor activity and anxiety in a neurotoxic parkinsonian mouse model.Methods: Parkinsonian mice exposed to neurotoxin underwent voluntary exercise (VE) and moderate forced exercise (FE). The motor activity levels were then measured using the rotarod and pole test. Anxiety was assessed using an open-field test (OFT) and elevated plus maze (EPM) test.Results: Bradykinesia, a motor dysfunction, was assessed using the pole test. The Tturn and Ttotal durations were significantly reduced in Parkinson-induced FE (p

___

  • 1. Goetz CG. The history of Parkinson’s disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med 2011; 1: a008862. [CrossRef]
  • 2. Williams-Gray CH, Worth PF. Parkinson’s disease. Medicine 2016; 44: 542-6. [CrossRef]
  • 3. Parent M, Parent A. Substantia nigra and Parkinson’s disease: a brief history of their long and intimate relationship. Can J Neurol Sci 2010; 37: 313-9. [CrossRef]
  • 4. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79: 368-76. [CrossRef]
  • 5. Pfeiffer RF. Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2016; 22: S119-22. [CrossRef]
  • 6. Dutra MF, Jaeger M, Ilha J, Kalil-Gaspar PI, Marcuzzo S, Achaval M. Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson’s disease. Neurol Sci 2012; 33: 1137-44. [CrossRef]
  • 7. Amara AW, Memon AA. Effects of Exercise on Non-motor Symptoms in Parkinson’s Disease. Clin Ther 2018; 40: 8-15. [CrossRef]
  • 8. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985; 100: 126-31.
  • 9. Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 2016; 15: 1257-72. [CrossRef]
  • 10. Ozsoy O, Tanriover G, Derin N, Uysal N, Demir N, Gemici B, et al. The effect of docosahexaenoic acid on visual evoked potentials in a mouse model of Parkinson’s disease: the role of cyclooxygenase-2 and nuclear factor kappa-B. Neurotox Res 2011; 20: 250-62. [CrossRef]
  • 11. Marques-Aleixo I, Santos-Alves E, Balça M, Rizo-Roca D, Moreira P, Oliveira P, et al. Physical exercise improves brain cortex and cerebellum mitochondrial bioenergetics and alters apoptotic, dynamic and auto (mito) phagy markers. Neuroscience 2015; 301: 480-95. [CrossRef]
  • 12. Tuon T, Valvassori SS, Lopes-Borges J, Luciano T, Trom CB, Silva LA, et al. Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson’s disease. Neuroscience 2012; 227: 305-12. [CrossRef]
  • 13. Lau YS, Patki G, Das‐Panja K, Le WD, Ahmad SO. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration. Eur J Neurosci 2011; 33: 1264-74. [CrossRef]
  • 14. Duman CH, Schlesinger L, Russell DS, Duman RS. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res 2008; 1199: 148-58. [CrossRef]
  • 15. Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, et al. Exercise exerts neuroprotective effects on Parkinson’s disease model of rats. Brain Res 2010; 1310: 200-7. [CrossRef]
  • 16. Ogawa N, Mizukawa K, Hirose Y, Kajita S, Ohara S, Watanabe Y. MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior. Eur Neurol 1987; 26(Suppl 1): 16-23. [CrossRef]
  • 17. Rozas G, Labandeira García JL. Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res 1997; 749: 188-99. [CrossRef]
  • 18. Bonito-Oliva A, Masini D, Fisone G. A mouse model of non-motor symptoms in Parkinson’s disease: focus on pharmacological interventions targeting affective dysfunctions. Front Behav Neurosci 2014; 8: 290. [CrossRef]
  • 19. Hall CS. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 1934; 18: 385-403. [CrossRef]
  • 20. Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, et al. Aging and Parkinson’s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 2018; 115: 80-91. [CrossRef]
  • 21. Alberts JL, Phillips M, Lowe MJ, Frankemolle A, Thota A, Beall EB, et al. Cortical and motor responses to acute forced exercise in Parkinson’s disease. Parkinsonism Relat Disord 2016; 24: 56-62. [CrossRef]
  • 22. Koo JH, Cho JY, Lee UB. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson’s disease. Exp Gerontol 2017; 89: 20-9. [CrossRef]
  • 23. Yoon YJ, Lee BH. Effects of balance and gait training on the recovery of the motor function in an animal model of Parkinson’s disease. J Phys Ther Sci 2014; 26: 905-8. [CrossRef]
  • 24. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, et al. Missing pieces in the Parkinson’s disease puzzle. Nat Med 2010; 16: 653-61. [CrossRef]
  • 25. Tuon T, Valvassori SS, Dal Pont GC, Paganini CS, Pozzi BG, Luciano TF, et al. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson’s disease. Brain Res Bull 2014; 108: 106-12. [CrossRef]
  • 26. Sasaki H, Hattori Y, Ikeda Y, Kamagata M, Iwami S, Yasuda S, et al. Forced rather than voluntary exercise entrains peripheral clocks via a corticosterone/noradrenaline increase in PER2: LUC mice. Sci Rep 2016; 6: 27607. [CrossRef]
  • 27. Taylor TN, Greene JG, Miller GW. Behavioral phenotyping of mouse models of Parkinson’s disease. Behav Brain Res 2010; 211: 1-10. [CrossRef]
European Journal of Therapeutics-Cover
  • ISSN: 2564-7784
  • Başlangıç: 1990
  • Yayıncı: Fatma Taşçı
Sayıdaki Diğer Makaleler

Data Analysis of 1811 Major Trauma Patients Admitted to the Emergency Departments of Thirteen Hospitals

Mustafa Onur ÖZTAN, Murat ANIL, Gökhan AKBULUT, Demet YALDIZ, Sadık YALDIZ

Evaluation the Effects of RME on Turkish Vowels: A Pilot Study

Merve GÖYMEN, Ayşegül GÜLEÇ, Güzin Bilgin BÜYÜKNACAR

The Efficacy of Pneumatic Compression Devices in the Treatment of Patients with Lymphedema after Mastectomy

Tomris DUYMAZ

The Efficacy of 0.2 Tesla Open Magnetic Resonance Imaging Scanner in the Diagnosis of Anterior Cruciate Ligament Injury

Ayşe Selcan KOÇ

Effect of Different Colors of Resin Cement and Stainability on the Final Color of CAD/CAM Materials

Derya SÜRMELİOĞLU, Özge PARLAR ÖZ, Nermin DEMİRKOL, Funda SOYSAL

Comparison of Success Rates of Pleurodesis with Talc, and Holmium-YAG Laser in the Patients with Malignant Pleural Effusion

Ahmet Feridun IŞIK, Ahmet ULUŞAN, Maruf ŞANLI, Ersin ARSLAN, Bülent TUNÇÖZGÜR, Seval KUL, Öner DİKENSOY, Levent ELBEYLİ

Biophysical Properties of ERG Channels in Octopus Neurons of Ventral Cochlear Nucleus

Caner YILDIRIM, Ramazan BAL

Treatment of High-Output Thoracic Chylous Fistula with Transabdominal Embolization of Cisterna Chyli: A Case Report and Review of the Literature

Emine Özlem GÜR, Selda GÜCEK HACIYANLI, Osman Nuri DİLEK, Mehmet HACIYANLI, Ömür BALLI, Oğuzhan ÖZŞAY, Volkan ÇAKIR

Diagnosis and Treatment of Bronchocentric Granulomatosis: A Rare Case Report

Mustafa KUZUCUOĞLU, Yeşim ALPAY, Figen ASLAN, Derya AYDIN

Management of Type 2 Diabetes Mellitus with Overweight: Focus on SGLT-2 Inhibitors and GLP-1 Receptor Agonists

Sergei V. JARGIN